Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer

por Hirsh, Vera
Publicado em 2010

Review of the treatment of metastatic non small cell lung carcinoma: A practical approach

por Hirsh, Vera
Publicado em 2011

Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer

por Hirsh, Vera
Publicado em 2012

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

por Hirsh, Vera
Publicado em 2014

Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?

por Hirsh, Vera
Publicado em 2013

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

por Hirsh, Vera
Publicado em 2014

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

por Hirsh, Vera
Publicado no Front Oncol (2015)

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib

por Hirsh, Vera
Publicado no BioDrugs (2015)

New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib

por Hirsh, Vera
Publicado no Onco Targets Ther (2017)

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

por Hirsh, Vera
Publicado no Ther Adv Med Oncol (2018)

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs

por Melosky, Barbara, Hirsh, Vera
Publicado em 2014

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

por Blais, Normand, Hirsh, Vera
Publicado em 2014

Optimal sequencing strategies in the treatment of EGFR mutation–positive non–small cell lung cancer: Clinical benefits and cost-effectiveness

por Hirsh, Vera, Singh, Jaspal
Publicado no Am J Health Syst Pharm (2020)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

por Morin-Ben Abdallah, Sami, Hirsh, Vera
Publicado no Front Oncol (2017)

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemot...

por Hirsh, Vera, Glaspy, John, Mainwaring, Paul, Manegold, Christian, Ramlau, Rodryg, Eid, Joseph E
Publicado em 2007

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

por Ascierto, Paolo A., Daniele, Bruno, Hammers, Hans, Hirsh, Vera, Kim, Joseph, Licitra, Lisa, Nanda, Rita, Pignata, Sandro
Publicado no J Transl Med (2017)

Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer

por Melosky, Barbara, Juergens, Rosalyn, Hirsh, Vera, McLeod, Deanna, Leighl, Natasha, Tsao, Ming‐Sound, Card, Paul B., Chu, Quincy
Publicado no Oncologist (2019)

Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients wit...

por Buttigliero, Consuelo, Shepherd, Frances A., Barlesi, Fabrice, Schwartz, Brian, Orlov, Sergey, Favaretto, Adolfo G., Santoro, Armando, Hirsh, Vera, Ramlau, Rodryg, Blackler, Adele R., Roder, Joanna, Spigel, David, Novello, Silvia, Akerley, Wallace, Scagliotti, Giorgio V.
Publicado no Oncologist (2018)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015

por Ascierto, Paolo A., Ascierto, Maria Libera, Formenti, Silvia, Gnjatic, Sacha, Hammers, Hans, Hirsh, Vera, Kiessling, Rolf, Melero, Ignacio, Nanda, Rita, Pawelec, Graham, Pignata, Sandro, Romero, Pedro, Speiser, Daniel E., Fox, Bernard A., Marincola, Francesco M.
Publicado no J Immunother Cancer (2016)

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

por Wu, Yi-Long, Sequist, Lecia V, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O'Byrne, Kenneth, Hirsh, Vera, Gibson, Neil, Massey, Dan, Kim, Miyoung, Yang, James Chih-Hsin
Publicado no Br J Cancer (2017)